Home > Archive > 2017 > 1

Volume 36, Number 1, pages 13-14

Journal Watch

Kathleen Wyne, M.D., Ph.D.

This column highlights recent clinical trial data and landmark clinical trials to provide readers with relevant information and links for obtaining trial data and articles to facilitate discussions with patients and other providers. It features the results of four trials: A Multicenter, Randomized, Double-Blind, Parallel- Group Study Comparing the Efficacy and Safety of Clonidine Topical Gel, 0.1% with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy A Multicenter, Randomized, Double Blind, Parallel- Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy A Multicenter Randomized, Double-Blind, Placebo- Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated with Painful Diabetic Neuropathy A Multicenter, Open-Label, Single-Arm Study to Evaluate the Long-Term Use of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated with Painful Diabetic Neuropathy

Clinical trials